Combination Assessment Trial of COVID-19 Vaccines (COMBAT-COVID)

NCT05162482 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

1680

Enrollment

OTHER

Sponsor class

Conditions

COVID 19 Vaccine

Interventions

BIOLOGICAL: BIBP (CNBG, Sinopharm) WIV
BIOLOGICAL: CanSinoBIO
BIOLOGICAL: AstraZeneca ChAdOx

Sponsor

Aga Khan University Hospital, Pakistan

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]